Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov
Condition: Solid Tumors
Study Type: Interventional
Phase: I
Study Start Date: 03/19/2019
Study Completion Date: 10/2024
The purpose of this study is to investigate the effects of nivolumab when given under the skin with or without rHuPH20.
This study will include participants with 1 of the following advanced or metastatic tumors approved for treatment with nivolumab monotherapy:
- non-small cell lung cancer (NSCLC)
- renal cell carcinoma (RCC)
- unresectable or metastatic melanoma
- hepatocellular carcinoma (HCC)
- microsatellite instability-high or mismatch repair deficient colorectal cancer (MSI-H/dMMR CRC)
- in Part B, other solid tumors may be considered at the discretion of the Medical Monitor